Atlas Trials

An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism

Clinical trial NCT04538989 · COMPLETED

Trial details

NCT number
NCT04538989
Sponsor
Rezolute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Congenital Hyperinsulinism
Start date
2020-02-24
Primary completion
2022-04-05
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.